Home ⟩ Insights

Insights

downgrades

3 min read • September 15, 2022

Is Fire & Flower Joining ‘The Discount Parade’? New Strategy Boosts Retail Cannabis Sales

1 min read • July 25, 2022

Cantor Fitzgerald Downgrades Auxly Cannabis Group to Neutral, Lowers Price Target to C$0.08

1 min read • May 14, 2021

Canaccord Genuity Downgrades Aurora Cannabis to Sell, Lowers Price Target to C$7

1 min read • May 11, 2021

CIBC Downgrades Aurora Cannabis to Underperformer, Lowers Price Target to C$9

1 min read • April 9, 2021

Stifel Downgrades Supreme Cannabis Co to Sell, Lowers Price Target to $0.4

1 min read • February 12, 2021

MKM Partners Downgrades Aurora Cannabis to Sell

1 min read • February 12, 2021

Needham Downgrades Aurora Cannabis to Underperform

1 min read • December 18, 2020

BMO Capital Downgrades Aurora Cannabis to Underperform, Announces C$9 Price Target

1 min read • November 16, 2020

Jefferies Downgrades Aurora Cannabis to Underperform

1 min read • November 11, 2020

Stifel Downgrades Aurora Cannabis to Sell, Raises Price Target to C$6.5

1 min read • October 27, 2020

Cantor Fitzgerald Downgrades Aurora Cannabis to Neutral, Lowers Price Target to C$7

1 min read • September 8, 2020

Ladenburg Thalmann Downgrades Aurora Cannabis to Neutral

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)